U.S. flag

An official website of the United States government

NM_015100.4(POGZ):c.3118G>A (p.Glu1040Lys) AND Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome

Germline classification:
Pathogenic (1 submission)
Last evaluated:
May 1, 2024
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV004555898.1

Allele description [Variation Report for NM_015100.4(POGZ):c.3118G>A (p.Glu1040Lys)]

NM_015100.4(POGZ):c.3118G>A (p.Glu1040Lys)

Gene:
POGZ:pogo transposable element derived with ZNF domain [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
1q21.3
Genomic location:
Preferred name:
NM_015100.4(POGZ):c.3118G>A (p.Glu1040Lys)
HGVS:
  • NC_000001.11:g.151405917C>T
  • NG_046601.1:g.58549G>A
  • NM_001194937.2:c.3091G>A
  • NM_001194938.2:c.2932G>A
  • NM_015100.4:c.3118G>AMANE SELECT
  • NM_145796.4:c.2833G>A
  • NM_207171.2:c.2959G>A
  • NP_001181866.1:p.Glu1031Lys
  • NP_001181867.1:p.Glu978Lys
  • NP_055915.2:p.Glu1040Lys
  • NP_665739.3:p.Glu945Lys
  • NP_997054.1:p.Glu987Lys
  • NC_000001.10:g.151378393C>T
  • NM_015100.3:c.3118G>A
Protein change:
E1031K
Links:
dbSNP: rs2102146729
NCBI 1000 Genomes Browser:
rs2102146729
Molecular consequence:
  • NM_001194937.2:c.3091G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001194938.2:c.2932G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_015100.4:c.3118G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_145796.4:c.2833G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_207171.2:c.2959G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome
Identifiers:
MONDO: MONDO:0014606; MedGen: C4225351; OMIM: 616364

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV005045043Clinical Genomics Laboratory, Washington University in St. Louis
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(May 1, 2024)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From Clinical Genomics Laboratory, Washington University in St. Louis, SCV005045043.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

The POGZ c.3118G>A (p.Glu1040Lys) variant has been reported in at least five individuals affected with White-Sutton syndrome or autism and is occurred de novo in at least four individuals (1, 5, 6, 7, 8). This variant has been reported in the ClinVar database as a germline pathogenic variant by one submitter. This variant is absent from the general population (gnomAD v.2.1.1), indicating it is not a common variant. Computational predictors are uncertain on the impact of this variant on POGZ function. Functional studies show conflicting results: at least one study indicates this variant may alter cellular localization (1) while another study indicates the variant does not alter localization and can rescue phenotype similar to the native protein (9). Based on available information and the ACMG/AMP guidelines for variant interpretation (10), this variant is classified as pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 26, 2024